Pro Share Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $36.5 Billion
  • Q2 2024

A detailed history of Pro Share Advisors LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 13,701 shares of ACRS stock, worth $28,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,701
Previous 17,450 21.48%
Holding current value
$28,635
Previous $21,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$1.01 - $1.36 $3,786 - $5,098
-3,749 Reduced 21.48%
13,701 $15,000
Q1 2024

May 08, 2024
BUY
$0.92 - $1.44 $1,315 - $2,059
1,430 Added 8.93%
17,450 $21,000
Q4 2023

Feb 14, 2024
BUY
$0.64 - $6.49 $1,511 - $15,322
2,361 Added 17.29%
16,020 $16,000
Q3 2023

Nov 13, 2023
BUY
$6.56 - $10.95 $347 - $580
53 Added 0.39%
13,659 $93,000
Q2 2023

Aug 10, 2023
BUY
$7.89 - $10.64 $10,872 - $14,661
1,378 Added 11.27%
13,606 $141,000
Q1 2023

May 11, 2023
SELL
$7.07 - $17.95 $11,312 - $28,720
-1,600 Reduced 11.57%
12,228 $98,000
Q4 2022

Feb 02, 2023
BUY
$14.33 - $18.37 $15,734 - $20,170
1,098 Added 8.63%
13,828 $217,000
Q3 2022

Nov 04, 2022
BUY
$13.07 - $18.22 $10,756 - $14,995
823 Added 6.91%
12,730 $201,000
Q2 2022

Aug 01, 2022
SELL
$10.16 - $17.08 $40,619 - $68,285
-3,998 Reduced 25.14%
11,907 $167,000
Q1 2022

May 10, 2022
SELL
$9.74 - $17.92 $37,547 - $69,081
-3,855 Reduced 19.51%
15,905 $274,000
Q4 2021

Feb 08, 2022
BUY
$12.27 - $18.49 $242,455 - $365,362
19,760 New
19,760 $287,000
Q3 2021

Nov 12, 2021
SELL
$13.38 - $18.8 $150,712 - $211,763
-11,264 Closed
0 $0
Q2 2021

Aug 13, 2021
BUY
$17.08 - $29.6 $192,389 - $333,414
11,264 New
11,264 $198,000
Q4 2019

Feb 12, 2020
SELL
$1.02 - $1.97 $15,004 - $28,978
-14,710 Closed
0 $0
Q3 2019

Nov 12, 2019
SELL
$0.79 - $2.47 $859 - $2,687
-1,088 Reduced 6.89%
14,710 $16,000
Q2 2019

Aug 13, 2019
SELL
$2.13 - $7.06 $4,168 - $13,816
-1,957 Reduced 11.02%
15,798 $35,000
Q1 2019

May 15, 2019
BUY
$5.63 - $7.84 $833 - $1,160
148 Added 0.84%
17,755 $106,000
Q4 2018

Feb 14, 2019
BUY
$6.3 - $15.4 $10,735 - $26,241
1,704 Added 10.71%
17,607 $130,000
Q3 2018

Nov 14, 2018
SELL
$14.38 - $20.89 $8,728 - $12,680
-607 Reduced 3.68%
15,903 $231,000
Q2 2018

Aug 13, 2018
SELL
$16.46 - $20.33 $11,818 - $14,596
-718 Reduced 4.17%
16,510 $330,000
Q1 2018

May 14, 2018
SELL
$17.08 - $25.64 $48,455 - $72,740
-2,837 Reduced 14.14%
17,228 $302,000
Q4 2017

Feb 14, 2018
BUY
$21.47 - $27.8 $430,795 - $557,807
20,065
20,065 $495,000

Others Institutions Holding ACRS

# of Institutions
97
Shares Held
52.4M
Call Options Held
32.4K
Put Options Held
3.3K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $139M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email